Advanced Alternative Payment Models

Advanced Alternative Payment Models
Name	Advanced Alternative Payment Models
Field	Health policy

Advanced Alternative Payment Models

Advanced Alternative Payment Models are provider-centered health care payment approaches designed to reward value and quality by aligning financial incentives with patient outcomes through population-based payments, shared savings, and bundled payments. Early prototypes emerged from policy debates involving Medicare, Centers for Medicare & Medicaid Services, Affordable Care Act, Department of Health and Human Services, and Congress stakeholders, and have been studied in demonstrations sponsored by Center for Medicare and Medicaid Innovation, RAND Corporation, Commonwealth Fund, Robert Wood Johnson Foundation, and Kaiser Family Foundation.

Overview and Definitions

Advanced Alternative Payment Models encompass physician-led Accountable Care Organization arrangements, bundled payment contracts, and capitated population health contracts that meet regulatory thresholds established by Centers for Medicare and Medicaid Services Innovation Center, Medicare Access and CHIP Reauthorization Act of 2015, and other frameworks. Descriptions draw on previous pilots such as Medicare Shared Savings Program, Bundled Payments for Care Improvement, Comprehensive Primary Care Plus, Next Generation ACO Model, and international analogues including payment reforms in United Kingdom, Australia, Canada, Germany, and Netherlands. Definitions distinguish between fee-for-service with bonuses, total-cost-of-care risk, and partial capitation, referencing techniques from Health Maintenance Organization histories, Prospective Payment System origins, and managed care contracts used by Blue Cross Blue Shield, UnitedHealthcare, Aetna, Cigna, and Humana.

Payment Model Types and Mechanisms

Common mechanisms include prospective bundled payments derived from episodes like hip replacement, coronary artery bypass grafting, and chemotherapy regimens; shared savings and shared risk in Accountable Care Organization contracts; and capitation used in Medicaid managed care and Medicare Advantage plans. Technical constructs rely on risk adjustment methods pioneered by Centers for Medicare and Medicaid Services Hierarchical Condition Category, Diagnostic Related Groups, and actuarial models used by Milliman and Society of Actuaries. Payment flows intersect with billing and coding systems such as Current Procedural Terminology, International Classification of Diseases, and National Drug Code, and contracting often involves legal frameworks influenced by Stark Law, Anti-Kickback Statute, False Claims Act, and Health Insurance Portability and Accountability Act.

Implementation and Operational Considerations

Operationalizing Advanced Alternative Payment Models requires clinical integration strategies from organizations like Mayo Clinic, Cleveland Clinic, Johns Hopkins Medicine, and Geisinger Health System, technology infrastructure using Electronic Health Record platforms from Epic Systems Corporation, Cerner Corporation, and Allscripts Healthcare Solutions, and analytics built with tools from IBM Watson Health, SAS Institute, and Google Health. Workforce changes reflect care team models adopted by Primary Care Collaborative, Institute for Healthcare Improvement, and National Committee for Quality Assurance, while data sharing invokes standards from Health Level Seven International, Fast Healthcare Interoperability Resources, and privacy rules interpreted under Office for Civil Rights (United States Department of Health and Human Services). Contract negotiation often involves legal counsel with precedents from cases before United States District Court, settlements involving Department of Justice, and guidance from American Medical Association policy.

Outcomes, Cost and Quality Evidence

Evaluations draw on randomized trials and quasi-experimental studies from New England Journal of Medicine, JAMA, Health Affairs, and reports from Congressional Budget Office, showing mixed impacts on spending, utilization, readmissions, and mortality in contexts including orthopedic surgery, cardiology, oncology, and diabetes mellitus. Meta-analyses by Cochrane Collaboration and systematic reviews by Agency for Healthcare Research and Quality examine quality measures endorsed by National Quality Forum and linked to patient-reported outcomes instruments developed by PROMIS. International comparisons reference outcomes reported by Organisation for Economic Co-operation and Development and case studies from National Health Service (England) and SickKids collaborations.

Regulatory, Legal, and Ethical Issues

Regulatory compliance intersects with administrative rules from Centers for Medicare and Medicaid Services, legal constraints under Stark Law and Anti-Kickback Statute, antitrust scrutiny by Federal Trade Commission, and litigation precedents involving False Claims Act prosecutions. Ethical debates engage bioethicists associated with The Hastings Center, Georgetown University Medical Center, Harvard Medical School, and policy critiques in forums such as The New England Journal of Medicine about access, equity, and potential patient selection practices criticized by AARP and civil rights advocates. Privacy and consent issues arise under Health Insurance Portability and Accountability Act jurisprudence and guidance from Office for Civil Rights (United States Department of Health and Human Services).

Stakeholder Roles and Incentives

Stakeholders include providers like American Medical Association, hospitals including Association of American Medical Colleges, payers such as Centers for Medicare and Medicaid Services, Medicare Advantage firms, employers represented by National Business Group on Health, and patient organizations including Patient-Centered Outcomes Research Institute and National Patient Advocate Foundation. Incentives link to performance metrics set by National Quality Forum and payment adjustments influenced by legislative actions in United States Congress and regulatory rulemaking by Department of Health and Human Services. Vendor roles involve Epic Systems Corporation, Cerner Corporation, consulting firms such as McKinsey & Company, Deloitte, and insurers like Blue Cross Blue Shield Association.

Challenges, Limitations, and Future Directions

Challenges include attribution complexity highlighted by studies in Health Affairs, data interoperability issues flagged by Office of the National Coordinator for Health Information Technology, and financial risk concerns raised by MedPAC. Limitations involve equity risks noted by Kaiser Family Foundation, measurement problems discussed in JAMA Internal Medicine, and scalability questions debated by Brookings Institution and Urban Institute. Future directions point to integration with precision medicine initiatives at National Institutes of Health, payment experiments supported by Center for Medicare and Medicaid Innovation, cross-border learning from Organisation for Economic Co-operation and Development, and advanced analytics from Google DeepMind and Microsoft Research to refine risk adjustment, social risk factor integration, and outcome alignment.

Category:Health policy